Clinical Trial Update: A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands [Phase 2]

View source ↗

Summary

Phase II study of dovitinib in recurrent or metastatic adenoid cystic carcinoma of the salivary glands has completed; this update notes the trial status and con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma of the Salivary Glands
• Salivary Gland Cancers

Drugs mentioned

• Dovitinib (dovitinib)

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Recurrent Adenoid Cystic Carcinoma of the Salivary Glands, Metastatic Adenoid Cystic Carcinoma of the Salivary Glands | Phase 2 | Status: COMPLETED